Olanib is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting. #Olanib150mg #Olaparib #AntiCancer #AntiViral #BreastCancer #KidneyCancer #LiverCancer https://iebpharma.com/product/olanib-olaparib-150mg